Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1842952 · CNTX

Context Therapeutics Inc.

Filing with the SEC SEC-reporting company Philadelphia, PA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Jul 31, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
  • Net loss in 2025Net loss of $36.1M for the year (2024: −$26.7M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$36.1M−$26.7M
Total assets$68.5M$98.1M
Total liabilities$8M$2.9M
Stockholders’ equity$60.5M$95.3M
Cash and equivalents$66M$94.4M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Context Therapeutics Inc.
Formerly: Context Therapeutics LLC
CIK
0001842952
Tickers
CNTX
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company; Emerging growth company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
Philadelphia, Pennsylvania
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 10, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 10, 2026 · filing · edition of Nov 10, 2026
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 5, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jul 31, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 6, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 23, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 5, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Sep 2, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 6, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 7, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 20, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Feb 28, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Jan 13, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 6, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Sep 4, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 7, 2024 · filing
  • Private raise (Form D)
    Form D · items 06b · filed May 16, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 8, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Mar 21, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 9, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 9, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 10, 2023 · filing
  • Restructuring or layoffs
    Form 8-K · items 2.02, 2.05, 7.01, 9.01 · filed Mar 22, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 2.05, 7.01, 9.01 · filed Mar 22, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 22, 2023 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jan 27, 2023 · filing